Table 2 Indicator results based on both datasets
Indicator | DSCA | EMR | Sensitivity | Specificity | PPV | NPV | PLR | NLR |
|---|---|---|---|---|---|---|---|---|
1 DSCA | (75/-) | (-/79) | - | - | - | - | - | - |
2 lymph nodes | 85% (39/46) | (-/36) | - | - | - | - | - | - |
3 meeting | 100% (29/29) | 70% (23/33) | 79% (23/29) | - (0/0) | 100% (23/23) | 0% (0/10) | - | - |
4 imaging | 88% (36/41) | 58% (31/53) | 58% (21/36) | 60% (3/5) | 67% (21/31) | 14% (3/44) | 1,45 | 0,7 |
5a chemotherapy | 80% (8/10) | - | - | - | - | - | - | - |
5b chemotherapy | 17% (1/6) | - | - | - | - | - | - | - |
6a CRM | 62% (18/29) | (-/33) | - | - | - | - | - | - |
6b CRM | 14% (4/29) | (-/33) | - | - | - | - | - | - |
7 radiotherapy | 92% (22/24) | - | - | - | - | - | - | - |
8b volume | 46 | 37 | - | - | - | - | - | - |